Neuroglobin, a pro-survival player in estrogen receptor a-positive cancer cells

Cell Death and Disease

Volumn 5, Issue 10, 2014, Pages

  Fiocchetti, M ^a   Nuzzo, M T ^a   Totta, P ^a   Acconcia, F ^a   Ascenzi, P ^a   Marino, M ^a  

^a ROMA TRE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; ESTROGEN RECEPTOR ALPHA; HYDROGEN PEROXIDE; NEUROGLOBIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN BCL 2; SHORT HAIRPIN RNA; ESTRADIOL; ESTROGEN RECEPTOR ALPHA, HUMAN; GLOBIN; NERVE PROTEIN;

ARTICLE; CANCER CELL; CANCER SURVIVAL; CELL NUCLEUS; CELL SURVIVAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; HELA CELL LINE; HEPG2 CELL LINE; MCF 7 CELL LINE; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STABILITY; UPREGULATION; APOPTOSIS; GENETICS; HUMAN; METABOLISM; NEOPLASM; PATHOPHYSIOLOGY; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; GLOBINS; HUMANS; NEOPLASMS; NERVE TISSUE PROTEINS;

EID: 84923288369     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.418     Document Type: Article

References (36)

1. Acconcia F, Totta P, Ogawa S, Cardillo I, Inoue S, Leone S et al. Survival versus apoptotic 17ß-estradiol effect: role of ERa and ERß activated non-genomic signaling. J Cell Physiol 2005; 203: 193-201.
2. Ascenzi P, Bocedi A, Marino M. Structure-function relationship of estrogen receptor a and ß: impact on human health. Mol Aspects Med 2006; 27: 299-402.
3. Burns KA, Korach KS. Estrogen receptors and human disease: an update. Arch Toxicol 2012; 86: 1491-1504.
4. Marino M. Xenoestrogens challenge 17ß-estradiol protective effects in colon cancer. World J Gastrointest Oncol 2014; 6: 67-73.
5. Nilsson S, Gustafsson JÅ. Estrogen receptors: therapies targeted to receptor subtypes. Clin Pharmacol Ther 2011; 89: 44-55.
6. Dupont S, Krust A, Gansmuller A, Dierich A, Chambon P, Mark M. Effect of single and compound knockouts of estrogen receptors a (ERa) and β (ERß) on mouse reproductive phenotypes. Development 2000; 127: 4277-4291.
7. Chen GG, Zeng Q, Tse GM. Estrogen and its receptors in cancer. Med Res Rev 2008; 28: 954-974.
8. Marquez DC, Chen HW, Curran EM, Welshons WV, Pietras RJ. Estrogen receptors in membrane lipid rafts and signal transduction in breast cancer. Mol Cell Endocrinol 2006; 246: 91-100.
9. Marino M, Ascenzi P. Membrane association of estrogen receptor a and ß influences 17ß-estradiol-mediated cancer cell proliferation. Steroids 2008; 73: 853-858.
10. Acconcia F, Marino M. The effects of 17ß-estradiol in cancer are mediated by estrogen receptor signaling at the plasma membrane. Front Physiol 2011; 2: 30.
11. Ascenzi P, Gustincich S, Marino M. Mammalian nerve globins in search of functions. IUBMB Life 2014; 66: 268-276.
12. De Marinis E, Ascenzi P, Pellegrini M, Galluzzo P, Bulzomi P, Arevalo MA et al. 17ß-estradiol - a new modulator of neuroglobin levels in neurons: role in neuroprotection against H2O2-induced toxicity. Neurosignals 2010; 18: 223-235.
13. De Marinis E, Fiocchetti M, Acconcia F, Ascenzi P, Marino M. Neuroglobin upregulation induced by 17ß-estradiol sequesters cytocrome c in the mitochondria preventing H2O2-induced apoptosis of neuroblastoma cells. Cell Death Dis 2013; 4: e508.
14. Fiocchetti M, De Marinis E, Ascenzi P, Marino M. Neuroglobin and neuronal cell survival. Biochim Biophys Acta 2013; 1834: 1744-1749.
15. Khan AA, Wang Y, Sun Y, Mao XO, Xie L, Miles E et al. Neuroglobin-overexpressing transgenic mice are resistant to cerebral and myocardial ischemia. Proc Natl Acad Sci USA 2006; 103: 17944-17948.
16. Jin K, Mao XO, Xie L, Khan AA, Greenberg DA. Neuroglobin protects against nitric oxide toxicity. Neurosci Lett 2008; 430: 135-137.
17. Emara M, Turner AR, Allalunis-Turner J. Hypoxic regulation of cytoglobin and neuroglobin expression in human normal and tumor tissues. Cancer Cell Int 2010; 10: 33.
18. Oleksiewicz U, Daskoulidou N, Liloglou T, Tasopoulou K, Bryan J, Gosney JR et al. Neuroglobin and myoglobin in non-small cell lung cancer: expression, regulation and prognosis. Lung Cancer 2011; 74: 411-418.
19. Zhang J, Lan SJ, Liu QR, Liu JM, Chen XQ. Neuroglobin, a novel intracellular hexa-coordinated globin, functions as a tumor suppressor in hepatocellular carcinoma via Raf/MAPK/Erk. Mol Pharmacol 2013; 83: 1109-1119.
20. Gorr TA, Wichmann D, Pilarsky C, Theurillat JP, Fabrizius ALaufs T et al. Old proteins - new locations: myoglobin, haemoglobin, neuroglobin and cytoglobin in solid tumours and cancer cells. Acta Physiol (Oxf) 2010; 202: 563-581.
21. Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nature Rev-Drug Discov 2013; 12: 931-947.
22. Burmester T, Hankeln T. What is the function of neuroglobin?. J Exp Biol 2009; 10: 1423-1428.
23. Marino M, Galluzzo P, Ascenzi P. Estrogen signaling multiple pathways to impact gene transcription. Curr Genomics 2006; 7: 497-508.
24. Galluzzo P, Caiazza F, Moreno S, Marino M. Role of ERß palmitoylation in the inhibition of human colon cancer cell proliferation. Endocr Relat Cancer 2007; 14: 153-167.
25. Essmann F, Engels IH, Totzke G, Schulze-Osthoff K, Janicke RU. Apoptosis resistance of MCF-7 breast carcinoma cells to ionizing radiation is independent of p53 and cell cycle control but caused by the lack of caspase-3 and a caffeine-inhibitable event. Cancer Res 2004; 64: 7065-7072.
26. Li D, Chen XQ, Li WJ, Yang YH, Wang JZ, Yu AC. Cytoglobin up-regulated by hydrogen peroxide plays a protective role in oxidative stress. Neurochem Res 2007; 32: 1375-1380.
27. Watanabe S, Takahashi N, Uchida H, Wakasugi K. Human neuroglobin functions as an oxidative stress-responsive sensor for neuroprotection. J Biol Chem 2012; 287: 30128-30138.
28. Cutrupi S, Ferrero G, Reineri S, Cordero F, De Bortoli M. Genomic lens on neuroglobin transcription. IUBMB Life 2014; 66: 46-51.
29. Shi L, Dong B, Li Z, Lu Y, Ouyang T, Li J et al. Expression of ER-a36, a novel variant of estrogen receptor a, and resistance to tamoxifen treatment in breast cancer. J Clin Oncol 2009; 27: 3423-3429.
30. Marino M, Acconcia F, Bresciani F, Weisz A, Trentalance A. Distinct nongenomic signal transduction pathways controlled by 17beta-estradiol regulate DNA synthesis and cyclin D(1) gene transcription in HepG2 cells. Mol Biol Cell 2002; 13: 3720-3729.
31. Brahimi-Horn MC, Chiche J, Pouyssegur J. Hypoxia and cancer. J Mol Med (Berl) 2007; 85: 1301-1307.
32. Wang X, Dykens JA, Perez E, Liu R, Yang S, Covey DF et al. Neuroprotective effects of 17ß-estradiol and nonfeminizing estrogens against H2O2 toxicity in human neuroblastoma SK-N-SH cells. Mol Pharmacol 2006; 70: 395-404.
33. Raychaudhuri S, Skommer J, Henty K, Birch N, Brittain T. Neuroglobin protects nerve cells from apoptosis by inhibiting the intrinsic pathway of cell death. Apoptosis 2010; 15: 401-411.
34. Polivka J Jr, Janku F. Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway. Pharmacol Ther 2014; 142: 164-175.
35. Bulzomi P, Bolli A, Galluzzo P, Acconcia F, Ascenzi P, Marino M. The naringenin-induced proapoptotic effect in breast cancer cell lines holds out against a high bisphenol a background. IUBMB Life 2012; 64: 690-696.
36. La Rosa P, Pesiri V, Marino M, Acconcia F. 17ß-Estradiol- induced cell proliferation requires estrogen receptor (ER) a monoubiquitination. Cell Signal 2011; 23: 1128-1135.